Not applicableStudy completedNCT01928836What this trial is testingRisk Stratification of Patients Using the Lung Cancer Biomarker Panel in ChinaWho this might be right forLung Neoplasms Bai Chunxue 764
Not applicableStudy completedNCT01741636What this trial is testingSurvivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung CancerWho this might be right forStage I Colon CancerStage I Rectal CancerStage IA Non-small Cell Lung Cancer+17 more City of Hope Medical Center 30
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Testing effectiveness (Phase 2)UnknownNCT01170923What this trial is testingFDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Asan Medical Center 100
Early research (Phase 1)Ended earlyNCT03927573What this trial is testingStudy With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA MarkerWho this might be right forNon-small Cell Lung CancerProstate CancerRenal Cancer+1 more AvenCell Europe GmbH 23
Not applicableUnknownNCT06564870What this trial is testingEfficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung CancerWho this might be right forBronchial Cancer University Hospital, Brest 200
Early research (Phase 1)Ended earlyNCT01891669What this trial is testingPF-06263507 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more Pfizer 26
Not applicableUnknownNCT01240369What this trial is testingAssociation Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell CarcinomaWho this might be right forVEGFC Protein in SerumVEGFC Protein in Non Small Cell Lung CancerVEGFC Protein in ESCC+2 more China Medical University Hospital 250
Large-scale testing (Phase 3)Study completedNCT00003869What this trial is testingCarboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung CancerWho this might be right forStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer National Cancer Institute (NCI) 186
Large-scale testing (Phase 3)Study completedNCT01652469What this trial is testingTesting of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.Who this might be right forCarcinoma, Non-Small-Cell Lung ETOP IBCSG Partners Foundation 81
Testing effectiveness (Phase 2)Study completedNCT03535740What this trial is testingBrigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or CeritinibWho this might be right forALK-positive Advanced NSCLC Ariad Pharmaceuticals 103
Very early researchStudy completedNCT04049474What this trial is testingBronchoscopic Cryo-Immunotherapy of Lung CancerWho this might be right forAdvanced Non-small Cell Lung Cancer NYU Langone Health 21
Large-scale testing (Phase 3)Looking for participantsNCT07185997What this trial is testingStudy to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsWho this might be right forNon-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more ArriVent BioPharma, Inc.
Testing effectiveness (Phase 2)UnknownNCT06231680What this trial is testingThalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)Who this might be right forLung Cancer, Nonsmall CellEsophageal Carcinoma Henan Cancer Hospital 132
Early research (Phase 1)Active Not RecruitingNCT05068102What this trial is testingTest How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking EzabenlimabWho this might be right forCarcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Boehringer Ingelheim 14
Testing effectiveness (Phase 2)Study completedNCT00002972What this trial is testingPaclitaxel in Treating Patients With Lung CancerWho this might be right forLung Cancer European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Study completedNCT02417701What this trial is testingSapanisertib in Treating Patients With Stage IV or Recurrent Lung CancerWho this might be right forRecurrent Lung Squamous Cell CarcinomaStage IV Lung Squamous Cell Carcinoma AJCC v7 National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT05226728What this trial is testingPharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung CancerWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 33
Testing effectiveness (Phase 2)Study completedNCT01725165What this trial is testingSurgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung CancerWho this might be right forRecurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7 M.D. Anderson Cancer Center 85
Large-scale testing (Phase 3)Active Not RecruitingNCT06396065What this trial is testingPhase III Study of AK112 for NSCLC PatientsWho this might be right forNon-Squamous Non-small Cell Lung Cancer Summit Therapeutics 420